Posters

Improvements of the Smart Pulse Technology to epi-LASEK outcomes

Poster Details

First Author: M. Camellin ITALY

Co Author(s):    S. Mosquera                    

Abstract Details

Purpose:

evaluate the clinical outcomes of the Smart Pulse Technology applied to epi-LASEK corrections with the SCHWIND AMARIS.

Setting:

DR. Massimo Camellin, Sekal Rovigo Microsurgery Centre, Rovigo, Italy

Methods:

32 eyes treated in epi-LASEK with the SCHWIND AMARIS Smart Pulse Technology have been retrospectively compared to a historic cohort of 32 matched eyes previously treated in epi-LASEK with the SCHWIND AMARIS ( without Smart Pulse Technology).

Results:

Smart Pulse Technology shows improved UDVA outcomes compared to previous epi-LASEK from Day 1 (4 lines better) to 1 month (0,5 lines better) postoperatively (p<0.05). At day 1 postoperatively, 66% of the Smart Pulse Technology treatments reach 20/40 or better, vs. only 17% of the previous epi-LASEK. Results become equivalent at 3 months (p>0.05).UDVA at Day 1 postoperatively averaged 0.28±0.19logMAR for Smart Pulse Technology and 0.64±0.21logMAR for the original AMARIS epi-LASEK (p<0.01). Postoperative Refractionsare similar (p>0.05) and excellent in both groups (mean SE +0.1±0.2D; mean Ast 0.3±0.3D).

Conclusions:

SmartSurfACE offers clear superiority in terms of visual recovery (CDVA and UDVA) for the short term (up to 1 month postoperatively) compared to the original AMARIS epi-LASEK.The short term superiority could be attributed to the improved residual roughness (enhanced smoothness) of the corneal surface.

Financial Disclosure:

NONE